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Abstract
Background: Although many biological databases are applying semantic web technologies, meaningful biological
hypothesis testing cannot be easily achieved. Database-driven high throughput genomic hypothesis testing
requires both of the capabilities of obtaining semantically relevant experimental data and of performing relevant
statistical testing for the retrieved data. Tissue Microarray (TMA) data are semantically rich and contains many
biologically important hypotheses waiting for high throughput conclusions.
Methods: An application-specific ontology was developed for managing TMA and DNA microarray databases by
semantic web technologies. Data were represented as Resource Description Framework (RDF) according to the
framework of the ontology. Applications for hypothesis testing (Xperanto-RDF) for TMA data were designed and
implemented by (1) formulating the syntactic and semantic structures of the hypotheses derived from TMA
experiments, (2) formulating SPARQLs to reflect the semantic structures of the hypotheses, and (3) performing
statistical test with the result sets returned by the SPARQLs.
Results: When a user designs a hypothesis in Xperanto-RDF and submits it, the hypothesis can be tested against
TMA experimental data stored in Xperanto-RDF. When we evaluated four previously validated hypotheses as an
illustration, all the hypotheses were supported by Xperanto-RDF.
Conclusions: We demonstrated the utility of high throughput biological hypothesis testing. We believe that
preliminary investigation before performing highly controlled experiment can be benefited.
Background
Biological databases are collections of scientific experi-
ments, published literatures, and computational analyses
organized under a specialized scheme. Biological databases
became essential resources to biologists in their daily
researches by providing information about biological facts
and experimental results and procedures and also by pro-
viding management tools for the obtained data. Because
these biological databases are designed for specific pur-
poses, and independently managed, and metadata are not
provided in many cases, they are neither semantically
explicit nor interoperable. To overcome these problems,
semantic web technologies such as Resource Description
Framework (RDF), Web Ontology Language (OWL) and
SPARQL (SPARQL Protocol and RDF Query Language)
have been actively accepted in the field of life science for
new database design [1-6]. Semantic web repositories are
more advantageous than relational databases (RDBs)
because metadata are more complete and standardized [7].
Representation of data as RDF makes biological entities
semantically explicit and clear so that various tasks can be
performed without extensive human interventions. These
tasks includes integration of heterogeneous data, applying
logic to infer new insights, and publication and sharing of
biological findings and models [8]. Several current
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knowledge management by applying semantic web tech-
nologies [1-4,6,9].
In spite of the benefits of semantic web technologies,
these databases cannot directly answer to biologists for
biologically meaningful questions or hypotheses. For
machines to answer these questions, the process of
inference based on either logical or statistical relation-
ships of stored data is required. The inference by
description logic is a part of semantic web technologies,
but statistical inference was not implemented in the cur-
rent semantic web technologies. These problems, there-
fore, cannot be solved within the framework of semantic
web technologies alone and are rather dependent on the
design of an application. However semantic web tech-
nologies are still beneficial in those applications.
To prove a biological hypothesis, 1) an experiment is
designed to test the hypothesis, 2) the experimental data
is gathered, and 3) the data is tested by statistical test(s).
Because of the increasing amount of high throughput
experimental data in biological databases, there is an
increasing need of high throughput validation of biologi-
cal hypotheses. To implement such an application, 1) a
hypothesis given by a user should be semantically inter-
preted, 2) the relevant experimental data should be
retrieved from the database, and then 3) the hypothesis
should be statistically tested against the retrieved data.
Besides the fact that tissue microarray (TMA) is being
widely used as a high throughput validation tool for the
large number of data-driven hypotheses from other
genomic technologies, TMA databases is a good candi-
date for the proof of concept of above mentioned appli-
cations. First, most biological hypotheses that can be
derived from only TMA experiment are syntactically
simple. The hypothesis derived from TMA experiments
can be stated as, “In a biological condition A, an entity
B is either positively or negatively correlated with an
entity C.” Basically a TMA experiment is designed to
test dependency between two entities and a hypothesis
about the mechanisms of the interactions between two
entities cannot be tested unless relevant additional infor-
mation is provided. There are two important biological
entities in TMA, biological samples and markers. In the
TMA-validated hypothesis, “Reduced expression of
Apaf-1 in colorectal cancer correlates with high-grade
phenotype” [10], for example, ‘colorectal cancer’ is bio-
logical condition, and “reduced Apaf-1 expression” and
“high-grade phenotype” are entities (B and C). Therefore
a dependency-stating hypothesis in a TMA experiment
can be considered as a triadic predicate with condition
A, entity B, and entity C as parameters. If these para-
meters are provided, a query for relevant data retrieval
can be generated through them. Second, only a few
kinds of statistical tests are generally used to test
hypothesis in TMA experiments. The main purpose of
TMA experiment is to test the statistical relationships
between biological entities (or markers) in a population
of samples with identical biological condition. The
results are determined by the size of the population
conforming to the given hypothesis. If more samples
show positive relationships with the hypothesis, the
hypothesis is more likely to be true.
Fisher’s exact and c
2 test are the most frequently used
statistical tests in TMA experiments to test dependency.
They are frequently used because most of clinical or his-
tological parameters (e.g., history of hypertension,
tumour grade, etc) and the extent or the intensity of the
marker expression in a tissue (e.g., 0, 1, 2, 3) have dis-
crete or categorical values and the dependencies
between these values are tested by them. For example, if
we want to test the above mentioned hypothesis,
“Reduced expression of Apaf-1 in colorectal cancer cor-
relates with high-grade phenotype.” by Fisher’s exact
test, we have to investigate each number of cores in
slides for four exclusive conditions : a) negative Apaf-1
expression and high-grade phenotype, b) negative Apaf-
1 expression and low-grade phenotype, c) weak to
strong Apaf-1 expression and high-grade phenotype,
and d) weak to strong Apaf-1 expression and low-grade
phenotype. Then these four parameters are used for
Fisher’s exact or c
2 test to test negative association
between Apaf-1 expression and histological grade.
In spite of these benefits of TMA database, if it were
not semantically explicit, applications for hypothesis
testing could not be implemented. TMA data have com-
plex and wide range of semantics, including information
for clinical and histopathological features and large
amount of metadata should be provided. Semantic web
technologies support richer semantics than traditional
RDB-based models. It, therefore, is more desirable that
the databases for applications for hypothesis testing
should be represented as RDF. In addition, SPARQL as
a query language is more intuitively understandable to
biologists [11]. Lastly, integration with the other data-
bases, including other TMA and DNA microarray data-
bases were considered in the present study and the
databases using semantic web technologies are more
advantageous in integration.
We have created and managed Xperanto-TMA, a
web-based TMA database supporting TMA-OM (Tissue
Microarray Object Model) [12] and TMA-TAB [13].
Xperanto-TMA uses RDB because technologies support-
ing object-oriented models were not mature enough to
guarantee high performance [12]. Due to the well orga-
nized object model, however, clear and rich semantic
relationships between entities are well supported. We
have also developed and managed a web-based DNA
microarray database called Xperanto [14].
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we extensively investigated semantics of experimental
data of TMA and DNA microarray. This experience
gave us good resources in constructing semantically rich
and explicit TMA and DNA microarray database repre-
sented as RDF. Because Xperanto-TMA and Xperanto
were independently developed, it was difficult to inte-
grate these two databases. The integration of gene
expression microarray and TMA data is a powerful
approach to molecular profiling of human cancer [15].
Semantic web gives us opportunity to integrate these
two databases through the use of ontology [9]. After
integration was achieved, we developed a use case where
the usefulness of the integration was found.
In this study, we present how we designed semantic
TMA database from the existing relational one and then
how applications let researchers test hypotheses using
semantic web infrastructures. Marker-level integration
of TMA and DNA microarray databases will be also
described.
Methods
RDF representation of TMA and DNA microarray data
Source databases
We represented Xperanto and Xperanto-TMA data as
RDF triples. The relational schema were derived from
TMA-OM by object-relational mapping [13]. The pri-
mary objective of Xperanto-TMA was to describe data
and metadata from TMA experiments in a structured
format with controlled vocabularies. Xperanto-TMA
hosts more than 100 TMA experiments for various
human cancers such as colon, gastric, and prostate can-
cers. For each experiment, detailed descriptions for clin-
ical and histopathologic features including histology,
grade, stage, and margin involvement are provided.
Staining results are also provided for detailed data ele-
ments such as staining intensity and range.
Xperanto, which supports Microarray Gene Expres-
sion-Object Model (MAGE) [16], was developed to pro-
vide integrated data management and analysis for
microarray data using user-friendly web-based interface
[14]. Xperanto can store and analyze data and metadata
from microRNA and ArrayCGH as well as DNA micro-
array experiment. It hosts more than 300 experiments
for 52 array platforms.
In addition to these data, data about the mapping of
DNA microarray probes to antibodies used in TMA
experiment was provided using Genome Research Infor-
matics Pipeline (GRIP, http://grip.snubi.org) to integrate
these two databases.
Ontology design and data representation as RDF
To provide RDF with a framework and facilitate the
process of integration, an ontology specific for our
applications was developed. In ontology design, our
previous studies to implement Xperanto and Xperanto-
TMA were referred because semantics in TMA and
DNA microarray experiments were already extensively
analyzed in the previous works [12,14]. Based on the
previous works, the ontology was expressed as OWL.
Part of the ontology is shown in Fig. 1(a) (Name spaces
are omitted for simplicity).
Reuse of the existing ontologies such as NCI thesaurus
or foundation model of anatomy (FMA) was not consid-
ered in this research because our main goal was to
prove a hypothesis-testing system could be implemented
with existing semantic web technologies and the goal
could be achieved with our application-specific ontology.
According to the scheme of the ontology, we made a
mapping rule for every data element (not shown) and
data in Xperanto-TMA and Xperanto was represented
as RDF. As in Fig. 1(b), for example, a row of Experi-
ment table with three columns was transformed into
two RDF triples. URIs for a subject were generated
using the value of the primary key and the column
names, “Name” and “ExpType” became predicates, “has-
Name” and “ExpType”.T h ev a l u e so ft h ec o l u m n s
became objects of the triples. Each instance of URIs is
an instance of an element (a class or a property) of the
ontology. Note that a value of a foreign key (Experimen-
tId in Slide table) was transformed into an object of a
triple, which was also a subject of another triple. In this
way, all the data in the selected tables of source data-
base could be represented as RDF triples.
System architecture
In the actual implementation of RDF representation, we
used a mediator system, D2RQ, instead of triple store
for transformed RDF triples. When a mediator system is
implemented, queries are directed against the mediator
and then the mediator translates the queries into multi-
ple SQLs for source RDBs. The use of mediator system
have been shown to scale better and be easier to main-
tain [9]. D2RQ is a java API which mediates RDB and
RDF-based applications according to an ontology and a
mapping rule. The applications based on D2RQ can use
SPARQL queries as if there were triple stores for the
SPARQLs. The SPARQLs, then, is conveyed to D2RQ
and D2RQ translates it into suitable SQL to the source
databases. When query results are returned, D2RQ
translate them into answers for the corresponding
SPARQL and send it to applications (Fig. 2).
Semantically-enabled hypothesis testing
Hypothesis model
We investigated the syntactic and semantic structures of
four scientific hypotheses, which were validated by
TMA experiments, from biomedical articles and pathol-
ogists. The hypotheses could be considered as triadic
predicates with three parameters, “In a biological
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Page 3 of 11Figure 1 Ontology and data representation as RDF (a) A part of the ontology for main entities represented as RDF graphs. C (pale blue
rectangles) represents classes, P (pink rectangles) properties, A anonymous nodes, empty arrows rdfs:subClassOf, pink arrows rdfs:domain, green
arrows rdfs:range, and red arrows owl:unionOf. (b) Relationship between data tables in a source database (Xperanto-TMA) and data graphs
represented as RDF graphs. Name spaces are omitted for simplicity. Violet ellipses represent classes, orange rectangles object properties, green
rectangles data type properties, and dotted arrows class-instance relationships.
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correlated with an entity C.” Factor A was defined as
shared properties among the samples, factor B as an
attribute and value set pair for distinct properties of the
samples classifying the samples into two groups (the
classifier), and factor C as an attribute and value set pair
for dependent properties of the samples on the classifier.
In a hypothesis, “Reduced expression of Apaf-1 in
colon cancer correlates with high-grade phenotype,” a
shared property corresponded to colon cancer, a classi-
fier to the reduced expression of Apaf-1 and dependent
property to high histological grade. In this hypothesis,
‘reduced expression of Apaf-1’ needed to be explicitly
stated through the process of the interpretation by
pathologists and it was interpreted as the value of stain-
ing intensity of Apaf-1 in tumor cells having “0”. On the
contrary, if “increased expression” had been used in the
hypothesis, it could have been interpreted as the value
having “1”, “2” or “3”, implying the complementary
value set against “0”.
B a s e do nt h e s ef i n d i n g s ,w em a d eam o d e lf o rt h e
hypothesis to investigate how a given hypothesis can be
analyzed with regards to TMA experimental data and
statistical test (Fig. 3(a)). To get relevant data to the
hypothesis, we needed data set where context was colon
cancer and “Apaf-1 Intensity” and “HistologicGrade”
were used as fields. Then we divided the selected data
set into two groups, Core Collection A and Core Collec-
tion B, whose value for “Apaf-1 Intensity” were “0” and
“1-3”, respectively. For each Core Collection A and B,
we obtained the distribution of the values for “Histolo-
gicGrade”, which were designated as “D1” and “D2”,
respectively. The element of distribution, D1 and D2
had a value, one among “High-grade”, “Intermediate-
grade”,a n d“Low-grade”. The hypothesis would be sup-
ported if D1 and D2 were significantly different by Fish-
er’s exact test. The other three hypothesis models were
constructed only by replacing the parameters of the
above mentioned model (Table 1).
The complementary value sets to the value sets of the
classifier and the dependent property were parts of the
hypothesis model, but they were not described in the
hypothesis and should be reasoned. If a value set of
either the classifier or the dependent property is pro-
vided, the complementary value set is generated as the
complementary set to the value set of it among the set
consisting of permissible value of the attribute of it.
Taking an example from the above mentioned hypoth-
esis, each of (“Low-grade”, “Intermediate-grade”)a n d
(“1”, “2”, “3”) was a complementary value set for the
Figure 2 System architecture of Xperanto-RDF.
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because the permissible value lists for each factor were
(“Low-grade”, “Intermediate-grade”, “High-grade”)a n d
(“0”, “1”, “2”, “3”), and “High-grade” and “0” was
described in the hypothesis. This process was implemen-
table because we had already defined permissible value
sets for every data element depending on the context
when implementing Xperanto-TMA [12,13].
Figure 3 Hypothesis model and procedures to test a hypothesis (a) Model of a hypothesis, “Reduced expression of Apaf-1 in colorectal
cancer correlates with high-grade phenotype”. (b) A statistical procedures for the hypothesis testing. Four SPARQLs are generated based on the
hypothesis model (the other three SPARQLS not shown). The returned values of four SPARQLs are delivered as four elements for Fisher’s exact
test.
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the applications for hypothesis testing, which were oper-
ated in three steps. First the applications received inputs
for the model construction. Second SPARQLs were gen-
erated according to the hypothesis model by a SPARQL
generator. Third the applications called a statistical
module and performed Fisher’s exact test using the
result set of SPARQLs.
SPARQL generation
Four SPARQLs were generated from each hypothesis
model by a SPARQL generator in the applications to
obtain four elements for Fisher’s exact test. For example,
the following is a SPARQL from the hypothesis model
in Fig. 3(a) to get one element of 2-by-2 matrix for Fish-
er’s exact test, which is a number of cores with negative
Apaf-1 expression and high-grade phenotype in colon
cancer (Fig. 3(b)). The SPARQLs have four phrases in
the WHERE clause and each phrase is independently
generated using a transforming function in the SPARQL
generator, Factor2SPARQL() having each factor and
either hypothesis-describing or its complementary value
set as parameters. The SPARQL is generated by conca-
tenating these four phrases.
Generally, SPARQLs are generated as in the
following.,
SPARQLi := “SELECT count(distinct ?cr) WHERE {” +
Σphraseij + “?sl xpe:Slide Block ?b. ?sl xpe:Slide_Repor-
ter ?r.}”
Phraseij := Factor2SPARQLj(Factorj, Valuesetij)
Valuesetij :i fj = 1, the shared properties among the
samples if ((i =1 ,3 )a n dj =2 )o r( ( i =1 ,2 )a n dj =3 ) ,
hypothesis-describing value set for Factorj, otherwise its
complementary value set
(i = 1, 2, 3,4, j =1 ,2 ,3 ) .
Statistical test for Fisher’s exact test
After SPARQLs are processed, the applications send a
list having four elements to the statistical module as
four elements for Fisher’s exact test. The statistical mod-
ule was made based on R (version 2.10.1., R Develop-
ment Core Team, Vienna). After processing, the
statistical module shows the p-value of the Fisher’s
exact test to the user. Based on this p-value, the user
can decide whether the database supports or rejects the
given hypothesis.
Use case of integrated TMA and DNA microarray
database
We designed a use case using integrated DNA and
TMA database, which was to find the distributions of
the histologies among the cores of TMA where the
intensities of the antibodies corresponding to the mar-
kers of interest in DNA microarray were high or low
Results
Xperanto-RDF
As described above, Xperanto-RDF was implemented
based on existing TMA and DNA microarray databases
(http://clara.snubi.org/Xperanto-RDF). Data from these
two databases were represented as RDF triples by a
mediator system such that users could have the benefits
of semantic web technologies as well as those of RDB.
Applications for hypothesis testing
A hypothesis model testing dependency can be con-
structed in the index page of Xperanto-RDF as shown
in Fig. 4 (http://clara.snubi.org/Xperanto-RDF). In the
context field, a user can choose the shared property
among the samples. The attribute of the classifier and
the dependent property can be selected by tracking
along the tree structure of the entity. Once the classifier
Table 1 Analysis of factors and their value sets of hypothesis and the results of statistical test (by Fisher’s exact test )
for the TMA data stored in Xperanto-RDF
Hypothesis Shared property
among samples
Classifier Dependent
property
Number of samples (cores)
/slides/experiments found
in Xperanto-RDF
P value
Reduced expression of Apaf-1 in colorectal carcinoma
correlates with high-grade phenotype [10].
Colon cancer Apaf-1
intensity
(0 vs. 1-3)
Grade
(High vs.
Low-grade)
55/5/3 < 0.0001
In gastric cancer, Apaf-1 expression is associated with
high grade malignancy.
Stomach caner Apaf-1
intensity
(0 vs. 1-3)
Grade
(High vs.
Low-grade)
52/4/3 < 0.0001
In colon cancer, the expression of Leptin is associated
with negative lymph node metastasis [19].
Colon cancer Leptin
(positive vs.
negative)
Nodal status
(N0 vs N1-N3)
52/4/3 < 0.0001
In gastric cancer patients, HDAC2 expression was
associated with negative lymph node metastasis [20].
Stomach caner HDAC2
expression
(positive vs.
negative)
Nodal status
(N0 vs N1-N3)
50/3/2 < 0.0001
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value set of the attribute is delivered to the select box to
the right side of the tree frame. Using the buttons
beside, the user can select hypothesis-describing and
complementary value sets. Then the relevant SPARQL is
generated by the SPARQL generator. On submitting the
SPARQLs, the applications perform the query against
the stored TMA data, the result sets are delivered to the
statistical module, and finally the result of the statistical
test including p-value is displayed.
As a result of hypothesis testing for the hypothesis in
Fig. 3, we found the following results from the TMA
database: 26 cores with Apaf-1 = 0 and high-grade phe-
notype, 4 cores with Apaf-1 ≥ 1 and high-grade pheno-
type, 6 core with Apaf-1 = 0 and low-grade phenotype,
and 19 cores with Apaf-1 ≥ 1 and low-grade phenotype.
These results support the given hypothesis because p
value for Fisher’s exact text for these data was less than
0.0001.
Table 1 shows the testing results of all of four hypoth-
eses. P value of the testing result determines whether
the hypothesis is accepted or rejected according to
Xperanto-RDF. With 0.01 of P value as a threshold for
the rejection of null hypothesis, all of four hypotheses
were accepted in these procedures. These results indi-
cate that TMA data in Xperanto-RDF supports all of
these hypotheses.
Use case using integrated TMA and DNA microarray
database
Xperanto-RDF achieved marker-mediated integration of
TMA and DNA microarray data by mapping of DNA
probes into antibodies in TMA experiment. By the use
of mapping data, we could execute some of semantically
integrated queries against data from TMA and DNA
microarray experiments. A use case for this system was
presented here.
Query: In an experiment for glioblastoma using Affy-
metrix HT Human Genome U133A array, the signal
from the probe, “201983_s_at” were interesting to a
researcher [17]. He wants to know the distribution of
histologies of the samples where the corresponding
Figure 4 Web interface to generate SPARQLs by selecting factors and their value sets.
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1) from our TMA database.
If TMA and DNA microarray database management
systems had not been semantically integrated, it would
have taken many steps to execute the queries and
furthermore we needed external data source that
showed what the corresponding antibody to the
“201983_s_at” probe is. In Xperanto-RDF, the queries
can be formulated as in Fig. 5. The query results show
that the corresponding antibody is EGFR and the most
predominant histological type among the samples where
EGFR is highly expressed in TMA is glioblastoma
according the data in Xperanto-RDF.
Discussion
We presented how a semantic database for TMA and
DNA microarray experiment can be developed from the
existing RDB implementations using currently available
semantic web technologies, how the application for
hypothesis testing using TMA experimental data was
designed and used, and how TMA database can be inte-
grated with DNA microarray database using semantic
web technologies.
We successfully implemented applications for hypoth-
esis testing and their usefulness was validated by testing
several experimentally validated biological hypotheses by
TMA experiments. Although the applications seems
useful to biologists, it is still challenging to spread the
idea of the hypothesis testing in the biological database
using experimental data to the whole community of the
biologists. In traditional biomedical research, an experi-
ment is designed to test a hypothesis [18] and it has
been believed that only a highly controlled experiment
could decide whether the hypothesis was true or false.
The value of hypothesis testing in the biological data-
b a s em a yb eq u e s t i o n a b l ef rom this point of view.
Despite the presence of the weakness, the future of
hypothesis testing using biological databases seems
bright. More experiments are getting open to the public
with detailed metadata about experiments and the
experiments tend to be industrialized and standardized.
As a result, it seems highly probable that a researcher
can find most of the experiments they want from the
biological databases in the near future. At present these
applications can be coupled with traditional biomedical
research in a cost effective way. A researcher can use
these applications as a preliminary investigation before
the highly controlled experiment is begun.
The applications for hypothesis testing can be
regarded as a semantically-enhanced meta-analysis tool
for TMA experiments in one aspect. One of require-
m e n t st op e r f o r mm e t a - a n a l y s i si st h ep r o c e s so fd a t a
normalization. Our applications do not have the process
of data normalization yet because there are no known
methods of normalization in TMA experiments. The
absence of normalization process do not appear to be
greatly influential on the experimental results at present
because TMA experiments are usually interpreted by
human eyes, crude categorical values are used in the
interpretation, and experimental procedures and inter-
pretations are rather standardized.
We separated the process of hypothesis model con-
struction, SPARQL execution, and statistical test when
implementing the applications for hypothesis testing.
This allows us more flexibility to easily manage and
develop the whole systems. More statistical modules will
be easily implemented to our applications if a hypothesis
cannot be tested with current statistical modules. We
will implement a statistical module for survival analysis
soon.
Post et al. suggested integrative bioinformatics experi-
mentation, defined as in silico data integration experi-
ment using semantic web technologies, and made a use
case to prove a hypothesis [7]. They tested a hypothesis
stating that histone modification and gene expression
regulation through transcription factor binding sites is
correlated, by integrating histone modification data and
transcription factor binding sites data derived from the
public database using semantic web technologies [7].
Their integrative bioinformatics experimentation cycle
consisted of hypothesis definition, experimental design,
data integration, extension of data integration experi-
ment, and data analysis and interpretation. Their study
was focused on the applicability of semantic web tech-
nologies to data integration phase. Compared to this
system, our applications process all the procedures to
test the hypothesis after the hypothesis is inserted. To
the user, the applications give impression as if the
machine directly answered for the questions. We believe
that we can implement the applications for hypothesis
testing because we used TMA experiment data rather
than genomic data and we targeted at the syntactically
simple hypotheses composed of three factors. We
believe that we can develop applications for testing for
more complicated hypotheses based on this experience
by treating complicated hypotheses as logical combina-
tions of multiple simple hypotheses.
From the beginning our TMA database was developed
with consideration on the integration with the other
TMA or omics databases. Any TMA database based on
TMA-OM can easily exchange the experimental data
and the direct implementation of our application for
hypothesis test is possible.
We also achieved marker-mediated integration of
TMA and DNA microarray database. The integration
enabled marker-mediated bidirectional data flow
between TMA and DNA microarray experimental data.
With these integrated databases, the results of DNA
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experiments.
Our future works are targeted in three directions.
First, we are developing hypothesis miner extracting bio-
logical hypotheses directly from biomedical literature
databases. The miner will feed hypotheses to TMA data-
bases without the insertion procedures by the user.
When realized, the integration of literature and experi-
mental databases mediated by the hypotheses can be
accomplished. Second, we will test if the same
applications can be applied to DNA microarray data-
bases using the same semantic web technologies.
Although data-driven approach is predominant in inter-
preting the DNA microarray experiment results, we
believe that traditional hypothesis-driven approach will
continue to give us new insights to perceive the biologi-
cal meaning of the DNA microarray experiment data.
Third, we will improve descriptive power of our applica-
tion-specific ontology and align it with existing ontolo-
gies. Our application specific ontology describes two
Figure 5 An integrated query against TMA and DNA microarray database This query returns a list of histological type of the samples which
show strong intensity (>1) for the corresponding antibody to the mRNA probe, “201983_s_at”. The corresponding antibody is EGFR.
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Because DNA microarray is usually describable by
MGED ontology, our ontology will become semantically
more powerful by relating it with MGED ontology.
Meanwhile, a part of our application-specific ontology
was made based on TMA-OM and there is no other
standard on ontology for TMA to the best of our
knowledge. We, therefore, will expand our application-
specific ontology so as to fully describe TMA experi-
ment and align it with other neighbourhood ontologies.
Conclusions
We proved semantic web technologies are beneficial in
statistical inference as well as in logical inference based
on description logic by implementing an application for
hypothesis testing without disrupting previously imple-
mented RDF-based applications. We proposed an appli-
cation in which biologist’s real interests are reflected.
The same scheme we used in developing Xperanto-RDF
could be applied to the other omics technologies. How-
ever extensive study on the semantic and syntactic
structure of the biologic hypothesis will more facilitate
the development of applications for hypothesis testing in
biological databases.
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